chr7-36396414-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000265748.7(ANLN):c.167G>A(p.Gly56Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000141 in 1,419,622 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000265748.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANLN | NM_018685.5 | c.167G>A | p.Gly56Asp | missense_variant | 2/24 | ENST00000265748.7 | NP_061155.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANLN | ENST00000265748.7 | c.167G>A | p.Gly56Asp | missense_variant | 2/24 | 1 | NM_018685.5 | ENSP00000265748 | P2 | |
ANLN | ENST00000396068.6 | c.167G>A | p.Gly56Asp | missense_variant | 2/23 | 1 | ENSP00000379380 | A2 | ||
ANLN | ENST00000424865.1 | c.101G>A | p.Gly34Asp | missense_variant | 2/4 | 3 | ENSP00000404979 | |||
ANLN | ENST00000418118.1 | c.101G>A | p.Gly34Asp | missense_variant | 2/2 | 3 | ENSP00000406584 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000851 AC: 2AN: 235020Hom.: 0 AF XY: 0.00000787 AC XY: 1AN XY: 127054
GnomAD4 exome AF: 0.00000141 AC: 2AN: 1419622Hom.: 0 Cov.: 30 AF XY: 0.00000142 AC XY: 1AN XY: 703526
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 19, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. This variant has not been reported in the literature in individuals affected with ANLN-related conditions. This variant is present in population databases (rs752908729, gnomAD 0.007%). This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 56 of the ANLN protein (p.Gly56Asp). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at